Author | Jonathan Xianglong Meng

Articles

Oslerian Genomics for Prostate Cancer Oncology

February 15, 2016

The great strength of the PCWG3 is the recognition that second- , third- , and fourth-line treatments offer new possibilities for extending overall survival.